Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01778647 · ClinicalTrials.gov registry record · Phase 4
Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD
A Phase 4 study, sponsored by Antonios Likourezos.
- Terminated
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT01778647 is a Phase 4 study that was terminated before completion, run by Antonios Likourezos. The registered enrollment target is 15 participants.
The verdict
NCT01778647, a Phase 4 study, was terminated before completion, sponsored by Antonios Likourezos.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
Multiple forms of Omega-3 Fatty acids have been used to investigate the role of this food supplement in children with Attention Deficit Hyperactivity Disorder (ADHD). No clear evidence for their role in this disorder is yet available. We will conduct a prospective, randomized, double blind, placebo controlled trial to obtain significant results regarding this question.
Interventions
- DIETARY_SUPPLEMENT Stimulants plus Lovaza
- DRUG Stimulants plus placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-12 |
| Est. Completion | 2010-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01778647
The ClinicalTrials.gov registry entry for NCT01778647 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Antonios Likourezos, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stimulants plus Lovaza is the first listed.
NCT01778647 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01778647 about?
NCT01778647 is a clinical study titled "Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD". Multiple forms of Omega-3 Fatty acids have been used to investigate the role of this food supplement in children with Attention Deficit Hyperactivity Disorder (ADHD). No clear evidence for their role in this disorder is yet available. We will conduct a prospective, randomized, double blind, placebo ...
What is the current status of trial NCT01778647?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2009-12. Estimated completion is 2010-07.
What interventions are being tested in trial NCT01778647?
The interventions under investigation include: Stimulants plus Lovaza (DIETARY_SUPPLEMENT), Stimulants plus placebo (DRUG).
Who is sponsoring clinical trial NCT01778647?
This trial is sponsored by Antonios Likourezos, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.